ArticleOncotarget2016

Absent and abundant MET immunoreactivity is associated with poor prognosis of patients with oral and oropharyngeal squamous cell carcinoma.

Maria J De Herdt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.